FDA Approved: ALLOPURINOL — Supplemental Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application from Gland Pharma Limited for Allopurinol, enabling the marketing of a generic Allopurinol product under ANDA 212363.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia
• Tumor Lysis Syndrome
• Uric Acid Nephrolithiasis

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

SUPPL AP for ALLOPURINOL (ALLOPURINOL)